All news
Update5d ago · Oct 27, 2026, 12:35 CET

Surgical Science Sweden up 74% since a director bought

Insider
Thomas Eklund
Role
Board member
Company
Surgical Science Sweden (SUS)
Transaction
Buy
Shares
262,588
Amount
SEK 8.3M
Trade date
Nov 27, 2025
Filed
Nov 28, 2025, 1 day after the trade

Thomas Eklund, a board member of Surgical Science Sweden, bought 262,588 shares at SEK 31.78 on Nov 27, 2025, for SEK 8.3M. At 12:34 CET on October 27, 2026 the stock traded at SEK 59.05, 73.9% above the first close after the purchase.

The purchase reached Finansinspektionen on November 28, 2025, 1 day after the trade. When it was filed, it was larger than each of the 10 earlier insider purchases of Surgical Science Sweden in our records since 2021.

Before the filing, 2 holders had disclosed net short positions in the company, together 2.03%. No sales by Thomas Eklund in Surgical Science Sweden have been reported since.

SUS +0.9% on the day, close Oct 30

Since purchase+73.9%SEK 33.96 → SEK 59.05 at 12:34 CET
Since filing+71.7%SEK 34.40 on Dec 1 → SEK 59.05
PurchaseSEK 8.3M262,588 shares on Nov 27, 2025
Days since purchase334No sales by this filer since

Price since the purchase

Daily close · SEK
+70%
0%
Nov 28 · first close 33.96 SEKOct 27 · 59.05 SEK
PurchaseFirst close above +70%

The filing

Pages in this item

Earlier news on Surgical Science Sweden

  1. Update4d agoSurgical Science climbs 80% since a director's purchase
  2. Update6d agoSurgical Science Sweden shares stand 72% above a director's purchase